The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase II study of sunitinib rechallenge in metastatic renal cell carcinoma (mRCC): A G.I.O.N. trial.
 
Camillo Porta
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Peloton Therapeutics; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Pfizer (Inst)
 
Vittorio D. Ferrari
No Relationships to Disclose
 
Paolo Andrea Zucali
No Relationships to Disclose
 
Giuseppe Fornarini
Consulting or Advisory Role - Astellas Oncology; Bayer Schering Pharma; Novartis; Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Antonio Bernardo
No Relationships to Disclose
 
Andrea Falconeri
No Relationships to Disclose
 
Alessandra Ferrari
No Relationships to Disclose
 
Sandra Santarossa
No Relationships to Disclose
 
Giovanni L. Pappagallo
Consulting or Advisory Role - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Janssen
 
Alessandra Bearz
No Relationships to Disclose